Aarti Pharmalabs Ltd.

The revenue for the September 2024 quarter is pegged at Rs. 3772.94 millions, about 5.94% up against Rs. 3561.43 millions recorded during the year-ago period.Profit saw a slight increase of 14.43%to Rs. 478.37  millions from Rs. 418.06 millions.Operating Profit saw a handsome growth to 877.20 millions from 737.98 millions in the quarter ended September 2024.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202409	202309	% Var	202409	202309	% Var	202403	202303	% Var
Sales	3772.94	3561.43	5.94	7707.80	7142.87	7.91	15021.30	15112.50	-0.60
Other Income	29.47	0.00	0.00	50.60	48.59	4.14	110.10	12.80	760.16
PBIDT	877.20	737.98	18.87	1734.88	1554.01	11.64	3571.60	3096.20	15.35
Interest	53.93	38.16	41.33	96.42	78.50	22.83	166.30	204.90	-18.84
PBDT	823.27	699.82	17.64	1638.46	1475.51	11.04	3405.30	2891.30	17.78
Depreciation	188.93	163.16	15.79	371.86	317.53	17.11	660.10	557.70	18.36
PBT	634.34	536.66	18.20	1266.60	1157.98	9.38	2745.20	2333.60	17.64
TAX	155.97	118.60	31.51	316.79	263.60	20.18	738.70	616.30	19.86
Deferred Tax	28.03	15.00	86.87	73.18	50.00	46.36	278.10	95.00	192.74
PAT	478.37	418.06	14.43	949.81	894.38	6.20	2006.50	1717.30	16.84
Equity	453.13	453.13	0.00	453.13	453.13	0.00	453.10	453.10	0.00
PBIDTM(%)	23.25	20.72	12.20	22.51	21.76	3.46	23.78	20.49	16.05